#AVCT trolls come and go. Prof Banerji, on the other hand, was principal investigator when @avacta’s AVA6000 trial began in 2021. 5+ years on, he’s still presenting data on preCISION’s tumour targeting to his #oncology peers at #ESMO2026. Speaks volumes.